Bilic M, Bumber Z, Blagaic AB, Batelja L, Seiwerth S, Sikiric P
Avoid layering GHK-Cu with strong actives like retinoids or AHAs in the same routine to reduce the risk of irritation
There is something out there
After treating HaCaT with 580 M CuCl 2 or Cu(OAc) 2 , the expression of IL1A, IL8, HSPA1A and FOSL1 were significantly higher than that in the control group and ranged from a 844 fold change
If the Phase 2a results hold, retatrutide could become the first truly effective pharmaceutical treatment for this condition
Perfil Anti-inflamatrio e Citoprotetor: adequado para investigaes sobre modulao da resposta inflamatria e defesa celular